Known only as “W115,” a 115 year old woman-before her death she was the oldest known living person-had her [MORE]
IBM may have pioneered nanopore technology, but other companies have advanced the field or found alternatives to faster DNA [MORE]
Life Technologies, Inc. (Carlsbad, CA)-formed from a 2008 merger of Invitrogen Corporation and Applied Biosystems-has reached an agreement with [MORE]
Suppose an outbreak of a new antibiotic- resistant pathogen appeared in one place and then another, and onward from [MORE]
In the race to realize “the $1,000 genome,” a small sequencing company, Ion Torrent (Guilford, CT) has moved the [MORE]
DNA sequencing (on microarrays) is competitive with contemporary biomarker-based PCR assays, on cost per assay target, sensitivity, specificity, assay protocol [MORE]
It has been 10 years since the publication of the first draft of the sequence of the human genome. This [MORE]
This past summer, life sciences instrument maker Illumina, Inc. (San Diego, CA) announced its founding of a collaboration [MORE]
RainDance, Inc.is in a storied location to start a revolution: Lexington, MA. The company is developing picoliter droplet-based microfluidics [MORE]
The Beijing Genomics Institute’s recent order of 126 DNA sequencers from Illumina, not only makes BGI the world’s largest [MORE]
The goal of a faster, less expensive sequencing-capable of reading an entire genome for $1,000–comes closer every month. Physicist [MORE]
Like the “Human Genome,” the “Mexican Genome” is an intellectual artifact, reflecting the broad strokes of mixing European, Native [MORE]
Besides figuring out new ways to run sequencers (e.g. IBM’s new nanopore approach, in the Nov. 3 Tagline), faster sample [MORE]
As genome sequencing technology becomes faster and cheaper, researchers such as Elaine Mardis, at Washington University School of Medicine (St. [MORE]
DNA sequencing typically requires restriction enzymes to chop up segments and then fluorescent dye labeling so the reader can detect [MORE]
No, the $1,000 genome has not yet seen the light of day, but hardly a week goes by without hearing [MORE]